Sanofi (SNY) Long-Term Investments (2009 - 2026)

Sanofi has disclosed Long-Term Investments across 18 years of filings, most recently posting $3.7 billion for Q2 2026.

• In Q2 2026, Long-Term Investments fell 7.57% year-over-year to $3.7 billion; the TTM figure through Jun 2026 stood at $3.7 billion (down 7.57% YoY), while the FY2025 annual figure was $3.8 billion, up 344.42% from the prior year.
• Long-Term Investments came in at $3.7 billion for Q2 2026 at Sanofi, up from -$377.0 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $4.0 billion in Q2 2025 to a low of -$1.7 billion in Q3 2025.
• Average Long-Term Investments over 5 years is $573.8 million, with a median of $337.7 million recorded in 2024.
• The largest YoY upside for Long-Term Investments was 1088.96% in 2025 against a maximum downside of 175.45% in 2025.
• Over 5 years, Long-Term Investments stood at $690.7 million in 2022, then sank by 33.95% to $456.2 million in 2023, then retreated by 25.98% to $337.7 million in 2024, then jumped by 1023.45% to $3.8 billion in 2025, then dropped by 1.74% to $3.7 billion in 2026.
• Per Business Quant data, the three most recent Long-Term Investments figures were $3.7 billion in Q2 2026, -$377.0 million in Q1 2026, and $3.8 billion in Q4 2025.